US Patent Issued to KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY on Oct. 28 for "Composition, for prevention or treatment of cancer disease, comprising cytotoxic T cells activated by T helper cell-derived extracellular vesicles as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,775, issued on Oct. 28, was assigned to KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Daegu, South Korea) and DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (Daegu, South Korea).

"Composition, for prevention or treatment of cancer disease, comprising cytotoxic T cells activated by T helper cell-derived extracellular vesicles as active ingredient" was invented by Moon-Chang Baek (Daegu, South Korea), Kyungmoo Yea (Daegu, South Korea), Do Kyung Jung (Daegu, South Korea), Suyeon Ryu (Daegu, South Korea), Sang Hee Shin (Busan, South Korea) and In Seong Jung (Daegu, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: ...